Hunan Jingfeng Pharmaceutical Co.,Ltd.
SHZ: 000908.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Li Zhang
- Employees
- 572
- Headquarters
- Shanghai, China
- IPO year
- 1999
- Market cap
- CN¥6.4B
- Website
- https://www.jfzhiyao.com
Loading 000908…
Loading profile data…Frequently asked questions about 000908
What does Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ) do?
Hunan Jingfeng Pharmaceutical Co.,Ltd. manufactures and sells chemical drugs and biological agents in China. The company's principal product is sodium hyaluronate injection for use in orthopedics and surgery applications. It also offers ophthalmology and API products, as well as engages in the research and development of anti-tumor, cancer, and...
Where does 000908.SZ trade?
Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ) trades on the Shenzhen Stock Exchange.
What sector is 000908.SZ in?
Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Hunan Jingfeng Pharmaceutical Co.,Ltd.?
Li Zhang is the chief executive officer of Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ).
Where is Hunan Jingfeng Pharmaceutical Co.,Ltd. headquartered?
Hunan Jingfeng Pharmaceutical Co.,Ltd. is headquartered in China.
Does 000908.SZ pay a dividend?
Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 000908.SZ go public?
Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ) completed its initial public offering in 1999.